SCHEMBL8178343

SCHEMBL8178343

CCOC(=O)c1cccc(Br)c1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.61
CA12 O43570 3/20 0.53
CA1 P00915 3/20 0.53
CA2 P00918 3/20 0.53
CA7 P43166 3/20 0.53
CA9 Q16790 3/20 0.53
CA14 Q9ULX7 3/20 0.53
ALDH1A1 P00352 2/20 0.53
HSD17B10 Q99714 1/20 0.53
RXFP1 Q9HBX9 2/20 0.51
GAA P10253 4/20 0.49
MAPT P10636 4/20 0.49
CDC25B P30305 3/20 0.49
CYP1A2 P05177 2/20 0.47
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
ALOX15 P16050 2/20 0.46
F2R P25116 1/20 0.46
KDM4E B2RXH2 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10571657 0.87 TSHR (0.73) TSHRCA12CA1CA2CA7
SCHEMBL265052 0.84 TSHR (0.63) TSHRCA12CA1CA2CA7
SCHEMBL1980259 0.84 TSHR (0.53) TSHRCA12CA1CA2CA7
SCHEMBL27268560 0.84 TSHR (0.66) TSHRALDH1A1HSD17B10CYP1A2KDM4E
SCHEMBL408906 0.84 TSHR (0.74) TSHRALDH1A1HSD17B10RXFP1GAA
SCHEMBL4626397 0.83 TSHR (0.61) TSHRCA12CA1CA2CA7
SCHEMBL1242911 0.82 GAA (0.66) TSHRCA12CA1CA2CA7
Bromide SCHEMBL15544606 0.82 TSHR (0.71) TSHRALDH1A1HSD17B10RXFP1GAA
SCHEMBL340364 0.82 CA12 (0.67) TSHRCA12CA1CA2CA7
SCHEMBL28628629 0.82 TSHR (0.71) TSHRALDH1A1HSD17B10RXFP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000078726-A1 IMIDAZOLINE DERIVATIVES FOR THE TREATMENT OF DIABETES, ESPECIALLY TYPE II DIABETES ELI LILLY AND COMPANY (US) 2000-12-28 WO disclosed